EVO200

About Evofem Biosciences

Evofem Biosciences is a mission-driven company focused on empowering women through innovative, non-hormonal contraceptive and sexual health products. Its key achievement is the FDA approval and commercial launch of Phexxi®, a first-in-class, on-demand contraceptive gel, complemented by the strategic acquisition of Solosec® for bacterial vaginosis. The company's strategy centers on commercial execution in the U.S., securing international partnerships, and advancing its pipeline based on its pH modulation technology to address significant unmet needs in women's healthcare.

Therapeutic Areas